Looking Into Bristol-Myers Squibb's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Bristol-Myers Squibb's (NYSE:BMY) short percent of float has fallen 3.33% since its last report, with 18.34 million shares sold short, which is 0.87% of all regular shares available for trading. This decrease in short interest could signal a more bullish sentiment towards the stock. However, it does not necessarily mean that the stock price will rise in the near term. Compared to its peers, Bristol-Myers Squibb has less short interest.
July 05, 2023 | 7:46 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Bristol-Myers Squibb's short interest has decreased, potentially indicating a more bullish sentiment towards the stock. However, this does not guarantee a rise in the stock price in the near term.
A decrease in short interest can indicate a more bullish sentiment towards a stock, as it means fewer investors are betting on the stock's price to fall. However, this does not necessarily translate into a rise in the stock price, as other market factors also play a role. Therefore, while the news is relevant to Bristol-Myers Squibb, its impact on the stock price is uncertain.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100